课题基金 / 基金详情

Mechanisms of cooperation between MAPK and PI3K signaling in melanoma

Mechanisms of cooperation between MAPK and PI3K signaling in melanoma
MAPK 和 PI3K 信号在黑色素瘤中的协同机制
批准号:
10247106
负责人:
JILLIAN SILVA
金额:
$17.91万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-06 至 2021-06-30
关键词:
AKT inhibitionAblationAdvisory CommitteesApoptosisAreaBRAF geneBiochemicalBiochemistryCRISPR/Cas technologyCancer BiologyCatalytic DomainCell CycleCell LineClinical TrialsCollectionComplexComprehensionDNA sequencingDataDevelopmentDiseaseEducational process of instructingEducational workshopEnvironmentEventEvolutionExhibitsFRAP1 geneFacultyFoundationsFrequenciesFundingGenesGeneticGenetic TranscriptionGenomicsGoalsGrowthGuide RNAHumanJournalsKnock-outLibrariesLipidsMAPK1 geneMAPK3 geneMEKsMaintenanceMalignant NeoplasmsMapsMediatingMelanoma CellMentorsMessenger RNAMitogen-Activated Protein KinasesModelingModificationMolecularMolecular TargetMutationNeoplasm MetastasisOncogenicPI3 genePIK3CA genePTEN genePathway interactionsPatientsPharmacologyPhosphatidylinositolsPhosphorylationPhosphotransferasesPlayPoint MutationPositioning AttributeProtein AnalysisProtein BiosynthesisProtein DephosphorylationProtein phosphataseProteinsProto-Oncogene Proteins c-aktPublishingRNA InterferenceResearchResearch PersonnelResearch Project GrantsResearch TrainingResistanceResourcesRibosomal Protein S6RibosomesRoleSecureSignal PathwaySignal TransductionSkin CancerTechnologyTestingTherapeuticTraining ActivityTraining ProgramsTranslatingTumor Suppressor Proteinscancer typecareercareer developmentcomparative genomic hybridizationdesigndistinguished professorgenetic effectorimprovedinhibitor/antagonistmelanocytemelanomamutantnext generationnovelpotential biomarkerprogramsprotein expressionpublic health relevanceresearch and developmentribosome profilingscreeningtargeted treatmenttooltumortumor xenograftwhole genome

项目摘要

项目成果

JILLIAN SILVA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Significance. Oncogenic mutations in BRAF and NRAS are among the most common genetic alterations that occur in melanoma leading to the sustained activation of the ERK1/2 mitogen-activated protein kinase (MAPK) pathway. Genetic aberrations in phosphoinositide 3-kinase (PI3K) signaling are also often required for melanoma progression and maintenance. Thus, the overarching goal of this research is to understand the underlying molecular and biochemical mechanisms of cooperation between the MAPK and PI3K signaling pathways that are essential for melanoma maintenance and to identify potential molecular targets that could contribute to the development of pathway-targeted therapy for melanoma patients. Approach. I will utilize cutting-edge screening technologies, such as a lentiCRISPR-Cas9 knockout library and ribosome profiling, to elucidate the genomic, transcriptional, and translational landscape of the melanoma cell and identify the major downstream effectors that are under the coordinate control of both the MAPK and PI3K signaling pathways. To understand the contribution of mutational activation of PIK3CA to the melanoma signaling networks, I will employ genetic and pharmacological inhibitory strategies and xenograft tumor models to test the synergistic antiproliferative effects of combined MAPK and PI3K pathway inhibition and the role of mTORC1 as a key integrator of MAPK and PI3K activity for PIK3CA mutant melanoma maintenance . Impact. The research proposed here will illuminate a greater comprehension of the mechanistic foundation of MAPK and PI3K pathway cooperation involved in melanoma signaling with direct implications in other types of cancer that share a similar molecular and biochemical landscape in which these pathway also cooperate. Environment. My primary mentor, Dr. Martin McMahon, is an Efim Guzik Distinguished Professor of Cancer Biology and a prominent leader in melanoma research. Moreover, Drs. Patricia Calarco and Davide Ruggero will be serving on my Advisory Committee to provide scientific expertise and guidance on career development. Career Goals. My comprehensive research training program includes expanding my research expertise into new technological areas, publishing my research in high-impact journals and establishing my own independent research program. In addition, I will also participate in the professional, career and teaching development workshops at UCSF to strengthen my competitiveness for attaining an academic faculty position and securing R-level funding. Furthermore, completion of these research and career development training activities will facilitate my progression into a highly successful independent investigator.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/pcmr.12586
发表时间: 2017-05
期刊: Pigment cell & melanoma research
影响因子: 4.3
作者: [Silva JM, Deuker MM, Baguley BC, McMahon M]
通讯作者: McMahon M
Mechanisms of cooperation between MAPK and PI3K signaling in melanoma
Mechanisms of cooperation between MAPK and PI3K signaling in melanoma
海外基金